211 related articles for article (PubMed ID: 18717994)
1. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
[TBL] [Abstract][Full Text] [Related]
4. Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus.
Kubo S; Kawasaki Y; Yamaoka N; Tagawa M; Kasahara N; Terada N; Okamura H
J Gene Med; 2010 Aug; 12(8):681-92. PubMed ID: 20635326
[TBL] [Abstract][Full Text] [Related]
5. Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer.
Yamamoto M; Davydova J; Wang M; Siegal GP; Krasnykh V; Vickers SM; Curiel DT
Gastroenterology; 2003 Oct; 125(4):1203-18. PubMed ID: 14517802
[TBL] [Abstract][Full Text] [Related]
6. Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells.
Kimura J; Ono HA; Kosaka T; Nagashima Y; Hirai S; Ohno S; Aoki K; Julia D; Yamamoto M; Kunisaki C; Endo I
Cancer Sci; 2013 Aug; 104(8):1083-90. PubMed ID: 23679574
[TBL] [Abstract][Full Text] [Related]
7. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.
Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A
Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies on treatment of pancreatic cancer with double-regulated duplicative adenovirus AdTPHre-hEndo carrying human endostatin gene.
Shan YF; Fang YF; Wang XQ; Jin R; Zhang QY; Andersson R
Pancreatology; 2013; 13(4):393-400. PubMed ID: 23890138
[TBL] [Abstract][Full Text] [Related]
10. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
Wirth T; Zender L; Schulte B; Mundt B; Plentz R; Rudolph KL; Manns M; Kubicka S; Kühnel F
Cancer Res; 2003 Jun; 63(12):3181-8. PubMed ID: 12810646
[TBL] [Abstract][Full Text] [Related]
11. Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment.
Hoffmann D; Wildner O
Mol Cancer Ther; 2006 Feb; 5(2):374-81. PubMed ID: 16505112
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
[TBL] [Abstract][Full Text] [Related]
13. Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy.
Kohno S; Nakagawa K; Hamada K; Harada H; Yamasaki K; Hashimoto K; Tagawa M; Nagato S; Furukawa K; Ohnishi T
Oncol Rep; 2004 Jul; 12(1):73-8. PubMed ID: 15201962
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic effect of Midkine promoter-based conditionally replicating adenoviruses expressing EGFR siRNA in head and neck squamous cancer cell line T891.
Uehara N; Otsuki N; Kubo M; Kitamoto J; Kojima Y; Teshima M; Shinomiya H; Shirakawa T; Nibu KI
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1231. PubMed ID: 32671980
[TBL] [Abstract][Full Text] [Related]
15. Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.
Adachi Y; Matsubara S; Muramatsu T; Curiel DT; Reynolds PN
J Pediatr Surg; 2002 Apr; 37(4):588-92. PubMed ID: 11912516
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].
Bouvet M; Bold RJ; Lee J; Evans DB; Abbruzzese JL; Chiao PJ; McConkey DJ; Chandra J; Chada S; Fang B; Roth JA
Ann Surg Oncol; 1998 Dec; 5(8):681-8. PubMed ID: 9869513
[TBL] [Abstract][Full Text] [Related]
17. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors.
Hernandez-Alcoceba R; Pihalja M; Wicha MS; Clarke MF
Hum Gene Ther; 2000 Sep; 11(14):2009-24. PubMed ID: 11020800
[TBL] [Abstract][Full Text] [Related]
18. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus.
Motoi F; Sunamura M; Ding L; Duda DG; Yoshida Y; Zhang W; Matsuno S; Hamada H
Hum Gene Ther; 2000 Jan; 11(2):223-35. PubMed ID: 10680837
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
20. Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2/neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide.
Liu X; Li J; Tian Y; Xu P; Chen X; Xie K; Qiu Z; Wang Y; Zhang D; Wolf F; Li C; Huang Q
Hum Gene Ther; 2010 Feb; 21(2):157-70. PubMed ID: 19751100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
